venlafaxine hydrochloride has been researched along with selegiline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gitlin, MJ | 1 |
| Creedon, TB; Hodgkin, D; Horgan, CM; Merrick, EL; Stewart, MT | 1 |
2 other study(ies) available for venlafaxine hydrochloride and selegiline
| Article | Year |
|---|---|
Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
Topics: Adult; Bipolar Disorder; Cyclohexanols; Dose-Response Relationship, Drug; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Selegiline; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride | 1997 |
Management of Newer Antidepressant Medications in U.S. Commercial Health Plans.
Topics: Antidepressive Agents; Citalopram; Cost Control; Cost Sharing; Desvenlafaxine Succinate; Drug Costs; Drug Utilization; Duloxetine Hydrochloride; Fluvoxamine; For-Profit Insurance Plans; Health Care Surveys; Health Services Accessibility; Humans; Insurance Coverage; Insurance, Pharmaceutical Services; Preferred Provider Organizations; Private Sector; Selegiline; United States; Venlafaxine Hydrochloride | 2015 |